TapewireFind a company

organization · Reporting owner

Pura Vida Master Fund, LTD

Disclosed activity across 1 company

Tapewire entity
127741
SEC CIK
0001912371

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

No relationships currently tracked through insider filings.

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

No balances currently tracked through insider filings.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

MedMen Enterprises, Inc.

Report date August 17, 2021 · Filed April 29, 2022

Jointly reported with PURA VIDA INVESTMENTS, LLC, Kamen Efrem

Section 16 reporting ended · disclosed 2022-04-29. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Senior Secured Convertible NoteSEC Table II · derivative / convertible security · Conversion / exercise price $0.17 · Expires 2028-08-17IndirectBy Pura Vida Master Fund, LTD.Not disclosed Reported balance After 2021-08-17 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2021-08-17 · Other · Disposed Not disclosed · Balance Not disclosed

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Senior Secured Convertible NoteSEC Table II · derivative / convertible security · Conversion / exercise price $0.15 · Expires 2028-08-17IndirectBy Pura Vida Master Fund, LTD.Not disclosed Reported balance After 2021-08-17 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2021-08-17 · Other · Disposed Not disclosed · Balance Not disclosed

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Senior Secured Convertible NoteSEC Table II · derivative / convertible security · Conversion / exercise price $0.34 · Expires 2028-08-17IndirectBy Pura Vida Master Fund, LTD.Not disclosed Reported balance After 2021-08-17 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2021-08-17 · Other · Disposed Not disclosed · Balance Not disclosed

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Senior Secured Convertible NoteSEC Table II · derivative / convertible security · Conversion / exercise price $0.28 · Expires 2028-08-17IndirectBy Pura Vida Master Fund, LTD.Not disclosed Reported balance After 2021-08-17 transaction · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · 2021-08-17 · Other · Disposed Not disclosed · Balance Not disclosed

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Senior Secured Convertible NoteSEC Table II · derivative / convertible security · Conversion / exercise price $0.17 · Expires 2028-08-17IndirectBy Pura Vida Pro Special Opportunity Master Fund, LTD.Not disclosed Reported balance After 2021-08-17 transaction · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · 2021-08-17 · Other · Disposed Not disclosed · Balance Not disclosed

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Senior Secured Convertible NoteSEC Table II · derivative / convertible security · Conversion / exercise price $0.15 · Expires 2028-08-17IndirectBy Pura Vida Pro Special Opportunity Master Fund, LTD.Not disclosed Reported balance After 2021-08-17 transaction · row 6 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 6 · 2021-08-17 · Other · Disposed Not disclosed · Balance Not disclosed

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Senior Secured Convertible NoteSEC Table II · derivative / convertible security · Conversion / exercise price $0.34 · Expires 2028-08-17IndirectBy Pura Vida Pro Special Opportunity Master Fund, LTD.Not disclosed Reported balance After 2021-08-17 transaction · row 7 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 7 · 2021-08-17 · Other · Disposed Not disclosed · Balance Not disclosed

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Senior Secured Convertible NoteSEC Table II · derivative / convertible security · Conversion / exercise price $0.28 · Expires 2028-08-17IndirectBy Pura Vida Pro Special Opportunity Master Fund, LTD.Not disclosed Reported balance After 2021-08-17 transaction · row 8 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 8 · 2021-08-17 · Other · Disposed Not disclosed · Balance Not disclosed

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $3.72 · Expires 2022-05-22IndirectBy Pura Vida Master Fund, LTD.234,753 Reported balance After 2021-08-17 transaction · row 9 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 9 · 2021-08-17 · Other · Disposed 435,971 · Balance 234,753

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $4.29 · Expires 2022-05-22IndirectBy Pura Vida Master Fund, LTD.67,818 Reported balance After 2021-08-17 transaction · row 10 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 10 · 2021-08-17 · Other · Disposed 125,947 · Balance 67,818

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $3.16 · Expires 2022-07-12IndirectBy Pura Vida Master Fund, LTD.69,074 Reported balance After 2021-08-17 transaction · row 11 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 11 · 2021-08-17 · Other · Disposed 128,279 · Balance 69,074

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $3.65 · Expires 2022-07-12IndirectBy Pura Vida Master Fund, LTD.19,955 Reported balance After 2021-08-17 transaction · row 12 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 12 · 2021-08-17 · Other · Disposed 37,058 · Balance 19,955

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $1.01 · Expires 2022-11-27IndirectBy Pura Vida Master Fund, LTD.86,322 Reported balance After 2021-08-17 transaction · row 13 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 13 · 2021-08-17 · Other · Disposed 160,311 · Balance 86,322

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $1.17 · Expires 2022-11-27IndirectBy Pura Vida Master Fund, LTD.24,938 Reported balance After 2021-08-17 transaction · row 14 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 14 · 2021-08-17 · Other · Disposed 46,313 · Balance 24,938

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $0.15 · Expires 2025-03-27IndirectBy Pura Vida Master Fund, LTD.4,349,248 Reported balance After 2021-08-17 transaction · row 15 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 15 · 2021-08-17 · Other · Disposed 8,077,175 · Balance 4,349,248

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $3.72 · Expires 2022-05-22IndirectBy Pura Vida Pro Special Opportunity Master Fund, LTD.74,132 Reported balance After 2021-08-17 transaction · row 16 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 16 · 2021-08-17 · Other · Disposed 137,675 · Balance 74,132

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $4.29 · Expires 2022-05-22IndirectBy Pura Vida Pro Special Opportunity Master Fund, LTD.21,416 Reported balance After 2021-08-17 transaction · row 17 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 17 · 2021-08-17 · Other · Disposed 39,773 · Balance 21,416

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $3.16 · Expires 2022-07-12IndirectBy Pura Vida Pro Special Opportunity Master Fund, LTD.21,813 Reported balance After 2021-08-17 transaction · row 18 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 18 · 2021-08-17 · Other · Disposed 40,509 · Balance 21,813

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $3.65 · Expires 2022-07-12IndirectBy Pura Vida Pro Special Opportunity Master Fund, LTD.6,301 Reported balance After 2021-08-17 transaction · row 19 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 19 · 2021-08-17 · Other · Disposed 11,703 · Balance 6,301

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $1.01 · Expires 2022-11-27IndirectBy Pura Vida Pro Special Opportunity Master Fund, LTD.27,259 Reported balance After 2021-08-17 transaction · row 20 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 20 · 2021-08-17 · Other · Disposed 50,625 · Balance 27,259

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $1.17 · Expires 2022-11-27IndirectBy Pura Vida Pro Special Opportunity Master Fund, LTD.7,875 Reported balance After 2021-08-17 transaction · row 21 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 21 · 2021-08-17 · Other · Disposed 14,625 · Balance 7,875

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $0.15 · Expires 2025-03-27IndirectBy Pura Vida Pro Special Opportunity Master Fund, LTD.1,373,447 Reported balance After 2021-08-17 transaction · row 22 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 22 · 2021-08-17 · Other · Disposed 2,550,687 · Balance 1,373,447

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Filing footnotes · ownership attribution and instrument terms

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F2: Currently exercisable.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
August 17, 2021 Filed Apr 29, 2022 20:45 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 2,550,687 Not disclosed Strike: $0.15 Not disclosed
Disclosure

SEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 22

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: 1,373,447

Underlying: Class B Subordinate Voting Shares · 3,924,133 shares

Expires 2025-03-27

F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2 · derivative.exercise_date: Currently exercisable.

F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
August 17, 2021 Filed Apr 29, 2022 20:45 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 14,625 Not disclosed Strike: $1.17 Not disclosed
Disclosure

SEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 21

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: 7,875

Underlying: Class B Subordinate Voting Shares · 22,500 shares

Expires 2022-11-27

F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2 · derivative.exercise_date: Currently exercisable.

F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
August 17, 2021 Filed Apr 29, 2022 20:45 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 50,625 Not disclosed Strike: $1.01 Not disclosed
Disclosure

SEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 20

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: 27,259

Underlying: Class B Subordinate Voting Shares · 77,884 shares

Expires 2022-11-27

F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2 · derivative.exercise_date: Currently exercisable.

F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
August 17, 2021 Filed Apr 29, 2022 20:45 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 11,703 Not disclosed Strike: $3.65 Not disclosed
Disclosure

SEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 19

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: 6,301

Underlying: Class B Subordinate Voting Shares · 18,004 shares

Expires 2022-07-12

F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2 · derivative.exercise_date: Currently exercisable.

F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
August 17, 2021 Filed Apr 29, 2022 20:45 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 40,509 Not disclosed Strike: $3.16 Not disclosed
Disclosure

SEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 18

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: 21,813

Underlying: Class B Subordinate Voting Shares · 62,322 shares

Expires 2022-07-12

F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2 · derivative.exercise_date: Currently exercisable.

F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
August 17, 2021 Filed Apr 29, 2022 20:45 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 39,773 Not disclosed Strike: $4.29 Not disclosed
Disclosure

SEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 17

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: 21,416

Underlying: Class B Subordinate Voting Shares · 61,189 shares

Expires 2022-05-22

F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2 · derivative.exercise_date: Currently exercisable.

F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
August 17, 2021 Filed Apr 29, 2022 20:45 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 137,675 Not disclosed Strike: $3.72 Not disclosed
Disclosure

SEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 16

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: 74,132

Underlying: Class B Subordinate Voting Shares · 211,807 shares

Expires 2022-05-22

F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2 · derivative.exercise_date: Currently exercisable.

F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
August 17, 2021 Filed Apr 29, 2022 20:45 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 8,077,175 Not disclosed Strike: $0.15 Not disclosed
Disclosure

SEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 15

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: 4,349,248

Underlying: Class B Subordinate Voting Shares · 12,426,422 shares

Expires 2025-03-27

F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2 · derivative.exercise_date: Currently exercisable.

F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
August 17, 2021 Filed Apr 29, 2022 20:45 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 46,313 Not disclosed Strike: $1.17 Not disclosed
Disclosure

SEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 14

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: 24,938

Underlying: Class B Subordinate Voting Shares · 71,250 shares

Expires 2022-11-27

F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2 · derivative.exercise_date: Currently exercisable.

F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
August 17, 2021 Filed Apr 29, 2022 20:45 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 160,311 Not disclosed Strike: $1.01 Not disclosed
Disclosure

SEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 13

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: 86,322

Underlying: Class B Subordinate Voting Shares · 246,633 shares

Expires 2022-11-27

F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2 · derivative.exercise_date: Currently exercisable.

F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
August 17, 2021 Filed Apr 29, 2022 20:45 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 37,058 Not disclosed Strike: $3.65 Not disclosed
Disclosure

SEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 12

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: 19,955

Underlying: Class B Subordinate Voting Shares · 57,013 shares

Expires 2022-07-12

F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2 · derivative.exercise_date: Currently exercisable.

F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
August 17, 2021 Filed Apr 29, 2022 20:45 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 128,279 Not disclosed Strike: $3.16 Not disclosed
Disclosure

SEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 11

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: 69,074

Underlying: Class B Subordinate Voting Shares · 197,353 shares

Expires 2022-07-12

F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2 · derivative.exercise_date: Currently exercisable.

F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
August 17, 2021 Filed Apr 29, 2022 20:45 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 125,947 Not disclosed Strike: $4.29 Not disclosed
Disclosure

SEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 10

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: 67,818

Underlying: Class B Subordinate Voting Shares · 193,765 shares

Expires 2022-05-22

F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2 · derivative.exercise_date: Currently exercisable.

F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
August 17, 2021 Filed Apr 29, 2022 20:45 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 435,971 Not disclosed Strike: $3.72 Not disclosed
Disclosure

SEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 9

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: 234,753

Underlying: Class B Subordinate Voting Shares · 670,724 shares

Expires 2022-05-22

F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2 · derivative.exercise_date: Currently exercisable.

F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
August 17, 2021 Filed Apr 29, 2022 20:45 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherSenior Secured Convertible Note · Derivative Not disclosed Not disclosed Strike: $0.28 $50,567.99
Disclosure

SEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 8

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: Not disclosed

Underlying: Class B Subordinate Voting Shares · 236,991 shares

Expires 2028-08-17

F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2 · derivative.exercise_date: Currently exercisable.

F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
August 17, 2021 Filed Apr 29, 2022 20:45 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherSenior Secured Convertible Note · Derivative Not disclosed Not disclosed Strike: $0.34 $2,046,495.53
Disclosure

SEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 7

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: Not disclosed

Underlying: Class B Subordinate Voting Shares · 8,025,472 shares

Expires 2028-08-17

F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2 · derivative.exercise_date: Currently exercisable.

F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
August 17, 2021 Filed Apr 29, 2022 20:45 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherSenior Secured Convertible Note · Derivative Not disclosed Not disclosed Strike: $0.15 $1,503,749.88
Disclosure

SEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 6

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: Not disclosed

Underlying: Class B Subordinate Voting Shares · 13,113,144 shares

Expires 2028-08-17

F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2 · derivative.exercise_date: Currently exercisable.

F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
August 17, 2021 Filed Apr 29, 2022 20:45 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherSenior Secured Convertible Note · Derivative Not disclosed Not disclosed Strike: $0.17 $1,101,959.13
Disclosure

SEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 5

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: Not disclosed

Underlying: Class B Subordinate Voting Shares · 8,642,816 shares

Expires 2028-08-17

F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2 · derivative.exercise_date: Currently exercisable.

F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
August 17, 2021 Filed Apr 29, 2022 20:45 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherSenior Secured Convertible Note · Derivative Not disclosed Not disclosed Strike: $0.28 $160,131.97
Disclosure

SEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 4

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: Not disclosed

Underlying: Class B Subordinate Voting Shares · 750,472 shares

Expires 2028-08-17

F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2 · derivative.exercise_date: Currently exercisable.

F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
August 17, 2021 Filed Apr 29, 2022 20:45 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherSenior Secured Convertible Note · Derivative Not disclosed Not disclosed Strike: $0.34 $6,480,570.00
Disclosure

SEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 3

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: Not disclosed

Underlying: Class B Subordinate Voting Shares · 25,414,000 shares

Expires 2028-08-17

F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2 · derivative.exercise_date: Currently exercisable.

F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
August 17, 2021 Filed Apr 29, 2022 20:45 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherSenior Secured Convertible Note · Derivative Not disclosed Not disclosed Strike: $0.15 $4,761,875.18
Disclosure

SEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 2

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: Not disclosed

Underlying: Class B Subordinate Voting Shares · 41,524,963 shares

Expires 2028-08-17

F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2 · derivative.exercise_date: Currently exercisable.

F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
August 17, 2021 Filed Apr 29, 2022 20:45 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherSenior Secured Convertible Note · Derivative Not disclosed Not disclosed Strike: $0.17 $3,489,537.69
Disclosure

SEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 1

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: Not disclosed

Underlying: Class B Subordinate Voting Shares · 27,368,923 shares

Expires 2028-08-17

F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2 · derivative.exercise_date: Currently exercisable.

F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
April 21, 2021 Filed Apr 29, 2022 20:43 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 1,259,035 Not disclosed Strike: $0.16 Not disclosed
Disclosure

SEC source: 0001209191-22-026282 · doc4.xml · derivative · entry 8

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: 0

Underlying: Class B Subordinate Voting Shares · 1,259,035 shares

Expires 2026-01-11

F1 · kind: Warrant cancelled for no consideration pursuant to terms of the Third Amended and Restated Securities Purchase Agreement dated January 11, 2021.

F2 · price: Not applicable.

F3 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F4 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
April 21, 2021 Filed Apr 29, 2022 20:43 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 506,250 Not disclosed Strike: $0.20 Not disclosed
Disclosure

SEC source: 0001209191-22-026282 · doc4.xml · derivative · entry 7

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: 0

Underlying: Class B Subordinate Voting Shares · 506,250 shares

Expires 2025-09-14

F1 · kind: Warrant cancelled for no consideration pursuant to terms of the Third Amended and Restated Securities Purchase Agreement dated January 11, 2021.

F2 · price: Not applicable.

F3 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F4 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
April 21, 2021 Filed Apr 29, 2022 20:43 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 194,712 Not disclosed Strike: $0.26 Not disclosed
Disclosure

SEC source: 0001209191-22-026282 · doc4.xml · derivative · entry 6

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: 0

Underlying: Class B Subordinate Voting Shares · 194,712 shares

Expires 2025-04-24

F1 · kind: Warrant cancelled for no consideration pursuant to terms of the Third Amended and Restated Securities Purchase Agreement dated January 11, 2021.

F2 · price: Not applicable.

F3 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F4 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
April 21, 2021 Filed Apr 29, 2022 20:43 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 973,558 Not disclosed Strike: $0.26 Not disclosed
Disclosure

SEC source: 0001209191-22-026282 · doc4.xml · derivative · entry 5

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: 0

Underlying: Class B Subordinate Voting Shares · 973,558 shares

Expires 2025-03-27

F1 · kind: Warrant cancelled for no consideration pursuant to terms of the Third Amended and Restated Securities Purchase Agreement dated January 11, 2021.

F2 · price: Not applicable.

F3 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F4 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
April 21, 2021 Filed Apr 29, 2022 20:43 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 3,986,944 Not disclosed Strike: $0.16 Not disclosed
Disclosure

SEC source: 0001209191-22-026282 · doc4.xml · derivative · entry 4

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: 0

Underlying: Class B Subordinate Voting Shares · 3,986,944 shares

Expires 2026-01-11

F1 · kind: Warrant cancelled for no consideration pursuant to terms of the Third Amended and Restated Securities Purchase Agreement dated January 11, 2021.

F2 · price: Not applicable.

F3 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F4 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
April 21, 2021 Filed Apr 29, 2022 20:43 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 1,603,125 Not disclosed Strike: $0.20 Not disclosed
Disclosure

SEC source: 0001209191-22-026282 · doc4.xml · derivative · entry 3

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: 0

Underlying: Class B Subordinate Voting Shares · 1,603,125 shares

Expires 2025-09-14

F1 · kind: Warrant cancelled for no consideration pursuant to terms of the Third Amended and Restated Securities Purchase Agreement dated January 11, 2021.

F2 · price: Not applicable.

F3 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F4 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
April 21, 2021 Filed Apr 29, 2022 20:43 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 616,587 Not disclosed Strike: $0.26 Not disclosed
Disclosure

SEC source: 0001209191-22-026282 · doc4.xml · derivative · entry 2

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: 0

Underlying: Class B Subordinate Voting Shares · 616,587 shares

Expires 2025-04-24

F1 · kind: Warrant cancelled for no consideration pursuant to terms of the Third Amended and Restated Securities Purchase Agreement dated January 11, 2021.

F2 · price: Not applicable.

F3 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F4 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
April 21, 2021 Filed Apr 29, 2022 20:43 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 3,082,933 Not disclosed Strike: $0.26 Not disclosed
Disclosure

SEC source: 0001209191-22-026282 · doc4.xml · derivative · entry 1

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: 0

Underlying: Class B Subordinate Voting Shares · 3,082,933 shares

Expires 2025-03-27

F1 · kind: Warrant cancelled for no consideration pursuant to terms of the Third Amended and Restated Securities Purchase Agreement dated January 11, 2021.

F2 · price: Not applicable.

F3 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F4 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 1,259,035 Not disclosed Strike: $0.16 Not disclosed
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 24

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: 1,259,035

Underlying: Class B Subordinate Voting Shares · 1,259,035 shares

Expires 2026-01-11

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F9 · kind: Warrant was issued pursuant to the Third Restatement. See also footnote (1).

F4 · price: Not applicable.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 3,214 Not disclosed Strike: $1.17 Not disclosed
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 23

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: 22,500

Underlying: Class B Subordinate Voting Shares · 25,714 shares

Expires 2022-11-27

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F8 · kind: Pursuant to the Third Restatement, a portion of the shares underlying this warrant was cancelled. See also footnote (1).

F4 · price: Not applicable.

F3 · derivative.exercise_date: Currently exercisable as of Reporting Date.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 11,127 Not disclosed Strike: $1.01 Not disclosed
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 22

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: 77,884

Underlying: Class B Subordinate Voting Shares · 89,011 shares

Expires 2022-11-27

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F8 · kind: Pursuant to the Third Restatement, a portion of the shares underlying this warrant was cancelled. See also footnote (1).

F4 · price: Not applicable.

F3 · derivative.exercise_date: Currently exercisable as of Reporting Date.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 2,572 Not disclosed Strike: $3.65 Not disclosed
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 21

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: 18,004

Underlying: Class B Subordinate Voting Shares · 20,576 shares

Expires 2022-07-12

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F8 · kind: Pursuant to the Third Restatement, a portion of the shares underlying this warrant was cancelled. See also footnote (1).

F4 · price: Not applicable.

F3 · derivative.exercise_date: Currently exercisable as of Reporting Date.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 8,903 Not disclosed Strike: $3.16 Not disclosed
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 20

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: 62,322

Underlying: Class B Subordinate Voting Shares · 71,225 shares

Expires 2022-07-12

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F8 · kind: Pursuant to the Third Restatement, a portion of the shares underlying this warrant was cancelled. See also footnote (1).

F4 · price: Not applicable.

F3 · derivative.exercise_date: Currently exercisable as of Reporting Date.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 8,741 Not disclosed Strike: $4.29 Not disclosed
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 19

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: 61,189

Underlying: Class B Subordinate Voting Shares · 69,930 shares

Expires 2022-05-22

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F8 · kind: Pursuant to the Third Restatement, a portion of the shares underlying this warrant was cancelled. See also footnote (1).

F4 · price: Not applicable.

F3 · derivative.exercise_date: Currently exercisable as of Reporting Date.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 30,259 Not disclosed Strike: $3.72 Not disclosed
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 18

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: 211,807

Underlying: Class B Subordinate Voting Shares · 242,066 shares

Expires 2022-05-22

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F8 · kind: Pursuant to the Third Restatement, a portion of the shares underlying this warrant was cancelled. See also footnote (1).

F4 · price: Not applicable.

F3 · derivative.exercise_date: Currently exercisable as of Reporting Date.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 3,986,944 Not disclosed Strike: $0.16 Not disclosed
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 17

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: 3,986,944

Underlying: Class B Subordinate Voting Shares · 3,986,944 shares

Expires 2026-01-11

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F9 · kind: Warrant was issued pursuant to the Third Restatement. See also footnote (1).

F4 · price: Not applicable.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 10,178 Not disclosed Strike: $1.17 Not disclosed
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 16

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: 71,250

Underlying: Class B Subordinate Voting Shares · 81,428 shares

Expires 2022-11-27

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F8 · kind: Pursuant to the Third Restatement, a portion of the shares underlying this warrant was cancelled. See also footnote (1).

F4 · price: Not applicable.

F3 · derivative.exercise_date: Currently exercisable as of Reporting Date.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 35,234 Not disclosed Strike: $1.01 Not disclosed
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 15

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: 246,633

Underlying: Class B Subordinate Voting Shares · 281,867 shares

Expires 2022-11-27

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F8 · kind: Pursuant to the Third Restatement, a portion of the shares underlying this warrant was cancelled. See also footnote (1).

F4 · price: Not applicable.

F3 · derivative.exercise_date: Currently exercisable as of Reporting Date.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 8,145 Not disclosed Strike: $3.65 Not disclosed
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 14

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: 57,013

Underlying: Class B Subordinate Voting Shares · 65,158 shares

Expires 2022-07-12

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F8 · kind: Pursuant to the Third Restatement, a portion of the shares underlying this warrant was cancelled. See also footnote (1).

F4 · price: Not applicable.

F3 · derivative.exercise_date: Currently exercisable as of Reporting Date.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 28,193 Not disclosed Strike: $3.16 Not disclosed
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 13

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: 197,353

Underlying: Class B Subordinate Voting Shares · 225,546 shares

Expires 2022-07-12

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F8 · kind: Pursuant to the Third Restatement, a portion of the shares underlying this warrant was cancelled. See also footnote (1).

F4 · price: Not applicable.

F3 · derivative.exercise_date: Currently exercisable as of Reporting Date.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 27,680 Not disclosed Strike: $4.29 Not disclosed
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 12

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: 193,765

Underlying: Class B Subordinate Voting Shares · 221,445 shares

Expires 2022-05-22

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F8 · kind: Pursuant to the Third Restatement, a portion of the shares underlying this warrant was cancelled. See also footnote (1).

F4 · price: Not applicable.

F3 · derivative.exercise_date: Currently exercisable as of Reporting Date.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 95,817 Not disclosed Strike: $3.72 Not disclosed
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 11

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: 670,724

Underlying: Class B Subordinate Voting Shares · 766,541 shares

Expires 2022-05-22

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F8 · kind: Pursuant to the Third Restatement, a portion of the shares underlying this warrant was cancelled. See also footnote (1).

F4 · price: Not applicable.

F3 · derivative.exercise_date: Currently exercisable as of Reporting Date.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherSenior Secured Convertible Note · Derivative Not disclosed Not disclosed Strike: $0.17 $1,403,716.39
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 10

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: Not disclosed

Underlying: Class B Subordinate Voting Shares · 8,257,155 shares

Expires 2022-04-23

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F7 · kind: This Note may be deemed issued for the purpose of Section 16 pursuant to the Third Restatement upon amendment of the conversion price of the original Notes. See also footnotes (1) and (2).

F4 · price: Not applicable.

F3 · derivative.exercise_date: Currently exercisable as of Reporting Date.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherSenior Secured Convertible Note · Derivative Not disclosed Not disclosed Strike: $0.78 $92,528.65
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 9

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: 0

Underlying: Class B Subordinate Voting Shares · 115,647 shares

Expires 2022-04-23

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F2 · kind: Pursuant to the Third Restatement, the conversion price of this Note was amended, which may be deemed a cancellation of the Note and an issuance of a new Note for the purpose of Section 16. See also footnotes (1) and (7).

F4 · price: Not applicable.

F3 · derivative.exercise_date: Currently exercisable as of Reporting Date.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherSenior Secured Convertible Note · Derivative Not disclosed Not disclosed Strike: $1.28 $174,678.90
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 8

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: 0

Underlying: Class B Subordinate Voting Shares · 132,700 shares

Expires 2022-04-23

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F2 · kind: Pursuant to the Third Restatement, the conversion price of this Note was amended, which may be deemed a cancellation of the Note and an issuance of a new Note for the purpose of Section 16. See also footnotes (1) and (7).

F4 · price: Not applicable.

F3 · derivative.exercise_date: Currently exercisable as of Reporting Date.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherSenior Secured Convertible Note · Derivative Not disclosed Not disclosed Strike: $2.17 $238,955.99
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 7

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: 0

Underlying: Class B Subordinate Voting Shares · 107,077 shares

Expires 2022-04-23

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F2 · kind: Pursuant to the Third Restatement, the conversion price of this Note was amended, which may be deemed a cancellation of the Note and an issuance of a new Note for the purpose of Section 16. See also footnotes (1) and (7).

F4 · price: Not applicable.

F3 · derivative.exercise_date: Currently exercisable as of Reporting Date.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherSenior Secured Convertible Note · Derivative Not disclosed Not disclosed Strike: $2.55 $897,552.85
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 6

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: 0

Underlying: Class B Subordinate Voting Shares · 341,847 shares

Expires 2022-04-23

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F2 · kind: Pursuant to the Third Restatement, the conversion price of this Note was amended, which may be deemed a cancellation of the Note and an issuance of a new Note for the purpose of Section 16. See also footnotes (1) and (7).

F4 · price: Not applicable.

F3 · derivative.exercise_date: Currently exercisable as of Reporting Date.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherSenior Secured Convertible Note · Derivative Not disclosed Not disclosed Strike: $0.17 $4,445,120.46
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 5

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: Not disclosed

Underlying: Class B Subordinate Voting Shares · 26,147,767 shares

Expires 2022-04-23

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F7 · kind: This Note may be deemed issued for the purpose of Section 16 pursuant to the Third Restatement upon amendment of the conversion price of the original Notes. See also footnotes (1) and (2).

F4 · price: Not applicable.

F3 · derivative.exercise_date: Currently exercisable as of Reporting Date.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.